Showing 20 of 123 recruiting trials for “Systemic lupus erythematosus”
Safety and Efficacy of ONT01 in Lupus
Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refractory Pediatric Rheumatic Diseases
👨⚕️ Meiping Lu, The Children's Hospital of Zhejiang University School of Medicine📍 1 site📅 Started Mar 2026View details ↗
Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases
👨⚕️ Qiubai Li, Professor, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology📍 1 site📅 Started Mar 2026View details ↗
Alnuctamab for Refractory SLE (LATTE Study)
👨⚕️ Chrisanna Dobrowolski, MD, Icahn School of Medicine at Mount Sinai School📍 1 site📅 Started Mar 2026View details ↗
A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132
Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases
Study of CD19 CAR-T Therapy for Refractory SLE
A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases
Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users
A Study to Evaluate the Safety,Tolerability,Pharmacokinetics and Pharmacodynamics of Cenerimod in Adult Chinese Participants With Moderate-to-severe Systemic Lupus Erythematosus (SLE)
RecruitingNCT07330245 ↗
Achievement of LLDAS5 in Patients With Systemic Lupus Erythematosus Treated With Anifrolumab.
A Phase I Study to Assess LBL-047 in Healthy Adults and Patients With Systemic Lupus Erythematosus
A Clinical Study of Dual-Target, Universal CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosus
👨⚕️ Mengtao Li, PhD, Peking Union Medical College Hospital📍 3 sites📅 Started Dec 2025View details ↗
The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
🏥 The Children's Hospital of Zhejiang University School of Medicine📍 1 site📅 Started Dec 2025View details ↗
Creating Health Course Study for People With Rheumatological Conditions
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Lupus
👨⚕️ Chadwick Prodromos, MD, The Foundation for Orthopaedics and Regenerative Medicine📍 2 sites📅 Started Dec 2025View details ↗
An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
Page 1 of 7Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →